tryptamine-4,5-dione has been researched along with Degenerative Diseases, Central Nervous System in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dryhurst, G; Wrona, MZ | 1 |
| Dryhurst, G; Jiang, XR; Wrona, MZ | 1 |
2 other study(ies) available for tryptamine-4,5-dione and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Oxidation of serotonin by superoxide radical: implications to neurodegenerative brain disorders.
Topics: Antioxidants; Brain Diseases; Free Radical Scavengers; Free Radicals; Glutathione; Humans; Indolequinones; Iron Chelating Agents; Neurodegenerative Diseases; Oxidation-Reduction; Protein Binding; Serotonin; Superoxides; Tryptamines | 1998 |
Tryptamine-4,5-dione, a putative endotoxic metabolite of the superoxide-mediated oxidation of serotonin, is a mitochondrial toxin: possible implications in neurodegenerative brain disorders.
Topics: Animals; Ascorbic Acid; Brain Chemistry; Electron Transport Complex IV; Endotoxins; In Vitro Techniques; Indolequinones; Male; Mitochondria; Neurodegenerative Diseases; Oxidation-Reduction; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Serotonin; Superoxides; Tryptamines | 1999 |